Alexander Pott1, Kerstin Petscher1, Marvin Messemer1, Wolfgang Rottbauer1, Tillman Dahme2. 1. Department of Medicine II, Ulm University Medical Center, Albert-Einstein-Allee 23, 89081, Ulm, Germany. 2. Department of Medicine II, Ulm University Medical Center, Albert-Einstein-Allee 23, 89081, Ulm, Germany. tillman.dahme@uniklinik-ulm.de.
Abstract
PURPOSE: Pulmonary vein isolation (PVI) with the cryoballoon is an established treatment for symptomatic atrial fibrillation. The second-generation cryoballoon increased efficacy in comparison to the first-generation cryoballoon. The third-generation cryoballoon was designed with a shorter distal tip to facilitate real-time recording of pulmonary vein (PV) isolation. Here, we compared the rate of real-time recordings of PVI of the second- and third-generation cryoballoon. METHODS: The incidence of real-time recording of PV isolation and time to PV isolation of the first 37 patients treated with the new third-generation cryoballoon at our center were compared to the last 37 patients treated with the second-generation cryoballoon. RESULTS: One hundred forty-nine pulmonary veins (PVs) were identified in each group. All PVs were isolated successfully with the second- or third-generation cryoballoon. Real-time registration of PVI occurred in 83 PVs (55.7 %) with the second-generation cryoballoon and in 124 PVs (83.2 %) with the third-generation cryoballoon (p < 0.001). The rate of observed real-time PVI was significantly higher with the third-generation cryoballoon for each individual PV. The time-to-isolation was 44 ± 25 s with the second-generation cryoballoon vs. 42 ± 22 s with the third-generation cryoballoon (p = 0.25). In a short-term clinical follow-up, there was no significant difference in atrial arrhythmia recurrence rates between both groups. CONCLUSIONS: The third-generation cryoballoon facilitates real-time recording of PV isolation with significantly higher rates of observed time-to-isolation. The time to PV isolation is not different between second- and third-generation cryoballoon.
PURPOSE:Pulmonary vein isolation (PVI) with the cryoballoon is an established treatment for symptomatic atrial fibrillation. The second-generation cryoballoon increased efficacy in comparison to the first-generation cryoballoon. The third-generation cryoballoon was designed with a shorter distal tip to facilitate real-time recording of pulmonary vein (PV) isolation. Here, we compared the rate of real-time recordings of PVI of the second- and third-generation cryoballoon. METHODS: The incidence of real-time recording of PV isolation and time to PV isolation of the first 37 patients treated with the new third-generation cryoballoon at our center were compared to the last 37 patients treated with the second-generation cryoballoon. RESULTS: One hundred forty-nine pulmonary veins (PVs) were identified in each group. All PVs were isolated successfully with the second- or third-generation cryoballoon. Real-time registration of PVI occurred in 83 PVs (55.7 %) with the second-generation cryoballoon and in 124 PVs (83.2 %) with the third-generation cryoballoon (p < 0.001). The rate of observed real-time PVI was significantly higher with the third-generation cryoballoon for each individual PV. The time-to-isolation was 44 ± 25 s with the second-generation cryoballoon vs. 42 ± 22 s with the third-generation cryoballoon (p = 0.25). In a short-term clinical follow-up, there was no significant difference in atrial arrhythmia recurrence rates between both groups. CONCLUSIONS: The third-generation cryoballoon facilitates real-time recording of PV isolation with significantly higher rates of observed time-to-isolation. The time to PV isolation is not different between second- and third-generation cryoballoon.
Entities:
Keywords:
Ablation; Atrial fibrillation; Cryoballoon; Short tip; Time-to-isolation
Authors: Alexander Fürnkranz; Stefano Bordignon; Daniela Dugo; Laura Perotta; Melanie Gunawardene; Britta Schulte-Hahn; Bernd Nowak; Boris Schmidt; Julian K R Chun Journal: J Cardiovasc Electrophysiol Date: 2014-05-02
Authors: Kudret Aytemir; Kadri Murat Gurses; Muhammed Ulvi Yalcin; Duygu Kocyigit; Muhammet Dural; Banu Evranos; Hikmet Yorgun; Ahmet Hakan Ates; Mehmet Levent Sahiner; Ergun Baris Kaya; Mehmet Ali Oto Journal: Europace Date: 2014-11-05 Impact factor: 5.214
Authors: Alexander Fürnkranz; Fabrizio Bologna; Stefano Bordignon; Laura Perrotta; Daniela Dugo; Boris Schmidt; Julian K R Chun Journal: Europace Date: 2016-03-02 Impact factor: 5.214
Authors: Douglas L Packer; Robert C Kowal; Kevin R Wheelan; James M Irwin; Jean Champagne; Peter G Guerra; Marc Dubuc; Vivek Reddy; Linda Nelson; Richard G Holcomb; John W Lehmann; Jeremy N Ruskin Journal: J Am Coll Cardiol Date: 2013-03-21 Impact factor: 24.094
Authors: Karl-Heinz Kuck; Josep Brugada; Alexander Fürnkranz; Andreas Metzner; Feifan Ouyang; K R Julian Chun; Arif Elvan; Thomas Arentz; Kurt Bestehorn; Stuart J Pocock; Jean-Paul Albenque; Claudio Tondo Journal: N Engl J Med Date: 2016-04-04 Impact factor: 91.245
Authors: Alexander Pott; Michael Baumhardt; Karolina Weinmann; Manuel Rattka; Tilman Stephan; Mirjam Keßler; Carlo Bothner; Kerstin Petscher; Wolfgang Rottbauer; Tillman Dahme Journal: Int J Cardiol Heart Vasc Date: 2019-04-30
Authors: Manuel Rattka; Alexander Pott; Anna Kühberger; Karolina Weinmann; Dominik Scharnbeck; Tilman Stephan; Michael Baumhardt; Carlo Bothner; Mario Iturbe Orbe; Wolfgang Rottbauer; Tillman Dahme Journal: Europace Date: 2020-09-01 Impact factor: 5.214
Authors: Alexander Pott; Hagen Wirth; Yannick Teumer; Karolina Weinmann; Michael Baumhardt; Christiane Schweizer; Sinisa Markovic; Dominik Buckert; Carlo Bothner; Wolfgang Rottbauer; Tillman Dahme Journal: Front Cardiovasc Med Date: 2021-12-14
Authors: Luigi Sciarra; Saverio Iacopino; Zefferino Palamà; Ermenegildo De Ruvo; Pasquale Filannino; Alessio Borrelli; Paolo Artale; Alberto Caragliano; Antonio Scarà; Paolo Golia; Lucia De Luca; Domenico Grieco; Marco Rebecchi; Stefano Favale; Leonardo Calò Journal: Indian Pacing Electrophysiol J Date: 2018-02-22